BNP Paribas Financial Markets
PLRX icon

BNP Paribas Financial Markets’s Pliant Therapeutics PLRX Stock Holding History

BNP Paribas Financial Markets’s Portfolio PLRX Stock Details PLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$749 Hold
657
– – ﹤0.01% 5634
2026
Q1 		$828 Hold
657
– – ﹤0.01% 5492
2025
Q4 		$802 Sell
657
-181,699
-100% -$273K ﹤0.01% 5424
2025
Q3 		$270K Buy
182,356
+27,665
+18% +$42.2K ﹤0.01% 3868
2025
Q2 		$179K Sell
154,691
-29,702
-16% -$42K ﹤0.01% 3809
2025
Q1 		$249K Buy
184,393
+176,881
+2,355% +$1.07M ﹤0.01% 3589
2024
Q4 		$98.9K Buy
+7,512
New +$103K ﹤0.01% 4166

Other funds holding PLRX

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
PLC
Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BNP Paribas Financial Markets's PLRX Position: Q2 2026 in Review

BNP Paribas Financial Markets held its Pliant Therapeutics (PLRX) position steady in Q2 2026 at 657 shares worth $749. The position accounts for ﹤0.01% of the portfolio, ranked #5634.

BNP Paribas Financial Markets first reported a position in PLRX in Q4 2024 and has held it in 7 quarters since. The position peaked at $270K in Q3 2025. 61 funds tracked by Wall St. Rank hold PLRX as of Q2 2026.

  • BNP Paribas Financial Markets held 657 shares of Pliant Therapeutics worth $749 as of Q2 2026.
  • BNP Paribas Financial Markets left its Pliant Therapeutics share count unchanged in Q2 2026.
  • Pliant Therapeutics made up ﹤0.01% of BNP Paribas Financial Markets's portfolio in Q2 2026, its #5634 holding.
  • BNP Paribas Financial Markets first reported a position in Pliant Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • BNP Paribas Financial Markets's Pliant Therapeutics position peaked at $270K in Q3 2025.
  • 61 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q2 2026.

Based on BNP Paribas Financial Markets's 13F filing for Q2 2026, filed 13 Aug 2026.